Loading...
Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market
BACKGROUND: Our study estimated insurance payments and patient out-of-pocket (OOP) expenses associated with discarded weight-based intravenous antineoplastic drugs for privately insured US adult patients with cancer. METHODS: We identified patients who received weight-based antineoplastic drugs from...
Saved in:
| Published in: | JNCI Cancer Spectr |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8328094/ https://ncbi.nlm.nih.gov/pubmed/34350376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkab045 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|